Strontium is a trace element that behaves like a slightly heavier stand-in for calcium. Because the two share similar chemistry, strontium follows calcium’s pathways into bone, where it gets incorporated into the mineral crystal structure and influences how bone is built and broken down. At therapeutic doses, strontium has a rare dual action: it encourages the cells that form new bone while discouraging the cells that dissolve old bone. That combination made it one of the more interesting osteoporosis drugs to emerge in recent decades, though cardiovascular safety concerns eventually narrowed its use. But strontium’s story in the body goes well beyond bone drugs, touching on tooth sensitivity, radioactive fallout, cancer pain treatment, and even ancient migration patterns.
How Strontium Gets Into Your Body and Where It Goes
You take in small amounts of strontium every day through food and water. It shows up in leafy greens, grains, seafood, and dairy, though the quantities are tiny compared to calcium. The body absorbs strontium through the same intestinal channels it uses for calcium. Research has shown that the epithelial calcium channel TRPV6, one of the main gatekeepers for calcium absorption in the gut, is also permeable to strontium ions.1Cell Calcium. Heavy metal cations permeate the TRPV6 epithelial cation channel Strontium absorption and excretion broadly mirror calcium handling, though some differences exist in how the kidneys process the two.2PubMed. Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism
Once absorbed, strontium travels through the bloodstream and parks itself overwhelmingly in the skeleton. About 99% of the strontium in your body resides in bone, with only trace amounts circulating in blood or ending up in soft tissues. In bone, strontium substitutes for a small fraction of calcium atoms within the hydroxyapatite crystals that give bone its rigidity. Under normal dietary conditions, only a tiny percentage of the calcium sites in bone mineral contain strontium instead. Even during treatment with strontium ranelate, studies using fluorescence mapping found that only the new bone formed during the treatment period contained meaningful amounts of strontium, with roughly 1 in 20 calcium atoms replaced.3Journal of Bone and Mineral Research. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment
The Dual Action on Bone Cells
What makes strontium biologically interesting is how it talks to the cells that manage bone remodeling. Bone is constantly being torn down by osteoclasts and rebuilt by osteoblasts. Most osteoporosis drugs work on one side of that equation: they either slow bone breakdown or, more rarely, speed up bone formation. Strontium does both at once.
Strontium ions activate the calcium-sensing receptor (CaSR) on bone cells, a receptor normally tuned to detect calcium levels.4PubMed Central. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment When osteoblasts sense strontium through this receptor, it nudges them toward differentiation and activity, increasing the formation of new bone nodules and the expression of markers associated with bone-building.5PubMed. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro Meanwhile, osteoclasts are suppressed. Their maturation slows, and even the ones that do form become less effective at dissolving bone because strontium disrupts the sealing zone they need to attach to the bone surface and start resorbing it.6Bone Reports. A review of the latest insights into the mechanism of action of strontium in bone This simultaneous push-pull on bone turnover has kept researchers interested in strontium for over three decades.
Strontium Ranelate and Fracture Prevention
The pharmaceutical application of this dual mechanism came in the form of strontium ranelate, a drug approved in Europe for postmenopausal osteoporosis. Two landmark trials established its fracture-reduction credentials. In the SOTI trial, postmenopausal women taking strontium ranelate for three years had roughly 41% fewer new vertebral fractures compared to those on placebo, with bone mineral density at the lumbar spine rising by about 14% over the same period.7PubMed. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis The companion TROPOS trial showed a 16% reduction in nonvertebral fractures across the full study population, and among high-risk older women with very low bone density, hip fracture risk dropped by about a third.8PubMed. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study Pooled analysis of both trials confirmed significant reductions in both vertebral and nonvertebral fractures regardless of baseline risk factors.9PubMed. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
There is a catch with the bone density numbers, though. Strontium is a heavier atom than calcium, so when it replaces calcium in bone, it absorbs more X-rays during a DXA scan. Part of the measured increase in bone mineral density reflects the physical presence of a denser element rather than a true increase in the amount of mineralized bone.10The Open Orthopaedics Journal. Essential Nutrients for Bone Health and a Review of their Availability in the Average North American Diet Researchers have estimated that roughly half of the DXA-measured bone density gain from strontium ranelate is an artifact of strontium’s heavier atomic weight rather than new bone formation. The fracture reductions are real and confirmed by clinical endpoints, but the bone density numbers on their own overstate the biological change.
Cardiovascular Safety Concerns
Strontium ranelate was never approved in the United States, and its use in Europe was progressively restricted after safety signals emerged. Pooled data from randomized trials showed a higher rate of heart attacks in patients taking strontium ranelate compared to placebo, with roughly 1.7% of treated patients experiencing a non-adjudicated myocardial infarction versus 1.1% on placebo.11PubMed Central. Cardiac concerns associated with strontium ranelate The signal largely disappeared when patients with pre-existing cardiovascular disease were excluded from the analysis. There was no increase in cardiovascular death in the trial data, but an elevated risk of blood clots was more consistently observed. A large multi-database study across five European countries found that current strontium ranelate users had about a 30% higher risk of venous thromboembolism compared to past users.12PubMed. Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance
The European Medicines Agency responded by restricting strontium ranelate to patients with severe osteoporosis who cannot use other treatments, and only in those without a history of heart disease, uncontrolled hypertension, or blood-clotting disorders. A review in Osteoporosis International summarized it neatly: strontium ranelate has clear anti-fracture efficacy but is associated with an increased risk of thromboembolic disease, while the heart attack signal remains uncertain and not confirmed by wider analyses.13PubMed Central. Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say?
Strontium Supplements and the Knowledge Gap
In the United States, where strontium ranelate was never available, strontium citrate has been sold over the counter as a dietary supplement for years. Standard doses of strontium citrate deliver about 680 mg of elemental strontium per day, which is roughly 170 to 340 times the amount you would normally get from food.14Journal of Nutrition Health & Food Science. Change in Bone Mineral Density with Strontium Citrate: An Illusion or Reality That dose is comparable to what strontium ranelate delivers, yet strontium citrate has undergone none of the rigorous safety testing that strontium ranelate did.
This matters because the cardiovascular risks, gastrointestinal side effects, rare allergic skin reactions, and the DXA artifact that apply to strontium ranelate plausibly apply to any form of strontium taken in similar quantities. The active ingredient is the strontium ion itself; ranelic acid, the other half of the ranelate molecule, is pharmacologically inert. People self-administering strontium citrate supplements are essentially getting the same element at the same dose without medical oversight, monitoring, or any data on long-term safety. Until controlled trials of strontium citrate are conducted, the cautious position is that the risks seen with strontium ranelate should be assumed to carry over.
What Happens When Strontium Levels Get Too High
At normal dietary intake, strontium is harmless. Problems arise when the ratio of strontium to calcium in the body shifts too far. Animal studies from the 1960s and 1970s provided the clearest picture. When rats were fed increasing levels of dietary strontium, their bones developed signs of poor mineralization: widened growth plates, uncalcified bone matrix, and lower mineral content. The damage became obvious when the calcium-to-strontium ratio in blood dropped below about 10 to 1.15Australasian Annals of Medicine. Strontium “rickets”: Bone, calcium and strontium changes
The underlying mechanism appears to involve vitamin D metabolism. High strontium intake in animal models blocked the production of the active form of vitamin D in the kidneys, which in turn impaired intestinal calcium absorption and led to a rickets-like condition. Giving the animals the active vitamin D metabolite directly reversed the problem, confirming that strontium was interfering with the conversion step rather than with the vitamin D receptor itself.16PubMed. Strontium induced rickets: metabolic basis People with kidney disease are at particular risk because impaired kidneys cannot clear excess strontium efficiently, allowing it to accumulate and potentially trigger the same mineralization defects.
Effects on Crystal Structure at Clinical Doses
Researchers have tried to pin down exactly how strontium changes bone at the crystal level. Synthetic hydroxyapatite loaded with strontium at levels mimicking clinical use (roughly 0.3% to 1.5% substitution) showed only modest changes: crystals grew slightly larger and the distribution of crystal sizes widened, but the fundamental crystal phase and composition stayed intact. At much higher levels, around 15% substitution, the crystal structure began to break down, crystallinity dropped sharply, and different chemical species appeared in the mineral.17PubMed. Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite The reassuring takeaway is that at the low incorporation rates seen with normal therapeutic dosing, strontium broadens the crystal size distribution in ways that may actually strengthen bone without fundamentally altering its mineral structure.
Strontium and Tooth Sensitivity
If you have ever used a toothpaste marketed for sensitive teeth, you may have already encountered strontium without knowing it. Strontium-based toothpastes, typically containing strontium acetate or strontium chloride, work by physically blocking the tiny tubules in exposed dentin that transmit pain signals to the nerve. In laboratory testing, a strontium acetate paste nearly fully occluded dentinal tubules and, uniquely among the products tested, maintained that occlusion even after extended acid challenge, outperforming both arginine-based and fluoride-only formulations at longer exposure times.18PubMed. Efficacy of desensitizing dentifrices to occlude dentinal tubules The mechanism is straightforward: strontium compounds form deposits that plug the tubule openings, reducing fluid flow and the pain it causes. This is one of strontium’s least controversial applications, with decades of commercial use behind it.
Strontium’s Other Life as a Cardiac Calcium Mimic
Bone is not the only tissue where strontium’s resemblance to calcium matters. In the heart, muscle contraction depends on tightly controlled calcium signaling. Strontium can enter heart cells through the same channels calcium uses and even trigger contraction, but it does so differently. Experiments replacing most of the external calcium with strontium in cardiac muscle preparations found that strontium could sustain contraction, but it prolonged the time to peak tension and altered the electrical behavior of the cells. Critically, strontium’s effects in this setting depended entirely on calcium channels in the cell membrane and not on the internal calcium stores in the sarcoplasmic reticulum.19PubMed. Can strontium replace calcium as an activator of internal calcium release in cardiac muscles? Further work showed that while calcium flowing into heart cells could trigger the release of strontium stored inside, strontium flowing in could not trigger release of more strontium, meaning the positive-feedback amplification loop that drives normal calcium signaling does not work with strontium as a substitute.20PubMed Central. Calcium-induced release of strontium ions from the sarcoplasmic reticulum of rat cardiac ventricular myocytes In vascular smooth muscle, strontium also accumulates in the sarcoplasmic reticulum and mitochondria, following the same storage compartments calcium uses.21PubMed. Strontium accumulation by sarcoplasmic reticulum and mitochondria in vascular smooth muscle These findings come from laboratory experiments rather than clinical observations, but they illustrate why dumping large amounts of strontium into the body could theoretically disrupt cardiac physiology, lending biological plausibility to the cardiovascular safety signals seen in the clinical trials.
Radioactive Strontium and Its Very Different Story
When people hear “strontium” in the context of health, they sometimes think of nuclear fallout rather than osteoporosis drugs. The concern is specifically about strontium-90, a radioactive isotope produced by nuclear fission. Because strontium-90 mimics calcium, the body absorbs it and deposits it in bone, where it lodges for years and irradiates the surrounding marrow. Research has shown that even brief low-concentration exposure to strontium-90 induces DNA double-strand breaks in bone marrow stromal cells, and chronic exposure impairs their ability to proliferate and support normal blood cell production.22PubMed Central. DNA damage induced by Strontium-90 exposure at low concentrations in mesenchymal stromal cells: the functional consequences
During the era of atmospheric nuclear weapons testing, strontium-90 entered the food chain through contaminated soil and grass, concentrated in milk, and ended up in children’s bones and teeth. A massive effort at Washington University collected over 300,000 baby teeth to document a sustained rise in strontium-90 levels during testing and a sharp decline after the 1963 test ban treaty.23PubMed. Strontium-90 in Baby Teeth as a Basis for Estimating U.S. Cancer Deaths From Nuclear Weapons Fallout Strontium-90 remains a concern around nuclear accidents and waste sites. The natural, stable strontium in food and supplements is an entirely different substance with no radioactivity, but the shared name creates persistent confusion.
Strontium-89 in Cancer Pain Management
Medicine has also found a use for a different radioactive strontium isotope: strontium-89 chloride, marketed as Metastron. Because strontium homes to bone, injecting a beta-emitting isotope intravenously delivers targeted radiation to bone metastases, the painful secondary tumors that commonly arise in advanced prostate and breast cancer. In a study of 76 patients, roughly two-thirds achieved good pain relief and about a quarter more had partial improvement, with reduced need for opioid painkillers.24PubMed. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer Larger institutional experience has confirmed these numbers, with over two-thirds of patients responding favorably and lowering their opioid doses after treatment.25PubMed Central. Strontium 89 in the treatment of pain due to diffuse osseous metastases: a university hospital experience The approach works because strontium-89 concentrates precisely where the cancer is growing in bone, delivering radiation locally while sparing most other tissues. It is not a cure, but for patients with widespread painful bone metastases, it can meaningfully improve quality of life.
Reading Ancient Migration Through Strontium in Teeth
One of strontium’s most creative applications has nothing to do with medicine. Archaeologists use naturally occurring strontium isotope ratios as a kind of geological fingerprint. Different rocks contain different proportions of strontium-87 and strontium-86, and those ratios pass from bedrock through soil, into local plants, into the food chain, and ultimately into the bones and teeth of people who eat that food. Because tooth enamel forms in childhood and does not remodel afterward, its strontium isotope ratio records the geology where a person grew up. Bone, by contrast, turns over throughout life and reflects the geology of wherever a person lived in their final years. When the enamel and bone ratios in the same skeleton differ, the person moved during their lifetime.26Journal of Archaeological Science. Immigration and the Ancient City of Teotihuacan in Mexico: a Study Using Strontium Isotope Ratios in Human Bone and Teeth
This approach has been used to trace migration patterns at the ancient city of Teotihuacan, identify immigrant communities in Roman-era Britain, and track population movements across prehistoric Europe. The method works because strontium isotope ratios are controlled primarily by the underlying geology, though factors like diet complexity and water sources add nuance to the interpretation.27PubMed. Passports from the past: Investigating human dispersals using strontium isotope analysis of tooth enamel It is a case where a trace element’s quiet, passive behavior in the body, simply following calcium into bone and staying there, turns out to be extraordinarily useful centuries after the person has died.
Strontium in Coral Skeletons and Climate Science
The same bone-seeking behavior that makes strontium useful in human medicine and archaeology shows up across the biological world. Reef-building corals incorporate strontium into their calcium carbonate skeletons, and for decades, climate scientists have used the strontium-to-calcium ratio in coral as a proxy for past sea temperatures. The basic idea is elegant: corals take up slightly more strontium at cooler temperatures, so measuring the ratio across seasonal growth bands can reconstruct water temperature year by year, going back centuries.
The reality, as with most things involving strontium, turned out to be more complicated. Spectroscopic work on coral skeletons found that strontium does not simply swap into calcium’s position in the aragonite crystal. At typical concentrations of around 7,500 parts per million, as much as 40% of the strontium sits in tiny domains of strontianite, a separate strontium carbonate mineral, rather than substituting into the aragonite lattice.28PubMed. Strontianite in coral skeletal aragonite And labeling experiments with a rare strontium isotope revealed that the distribution of newly incorporated strontium within the coral skeleton is strikingly uneven, challenging the simple models geochemists had used.29Geophysical Research Letters. Strontium‐86 labeling experiments show spatially heterogeneous skeletal formation in the scleractinian coral Porites porites Strontium-to-calcium paleothermometry still works as a broadly useful tool, but calibrating it requires accounting for biological processes in the coral that modulate strontium uptake independently of temperature.30Geochimica et Cosmochimica Acta. Incorporation of strontium into reef coral skeletal carbonate